Results 191 to 200 of about 19,146 (219)

Changes in detrusor muscle oxygenation during detrusor overactivity contractions

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
To investigate changes in the oxygenated and deoxygenated haemoglobin (Hb) of the bladder wall during voluntary and involuntary detrusor contractions.Women with lower urinary tract symptoms were recruited from a urodynamics clinic. Near infra-red spectroscopy, a non-invasive optical technique which monitors changes in tissue oxygenation, was used to ...
Gopalan, Vijaya, Giuseppe A, Digesu, Alexandros, Derpapas, Demetri C, Panayi, Ruwan, Fernando, Vik, Khullar   +5 more
openaire   +2 more sources

Antimuscarinic Mechanisms and the Overactive Detrusor: An Update

European Urology, 2011
Antimuscarinics are the drugs of choice for the treatment of detrusor overactivity (DO) and overactive bladder (OAB) syndrome. However, the mechanisms for their beneficial effects have not yet been definitely established.Literature available on the pathophysiologic aspects of storage symptoms and of antimuscarinic actions on the bladder was reviewed ...
openaire   +2 more sources

The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity

Neurourology and Urodynamics, 2009
AbstractAimsTo investigate the association of both the urodynamic profiles and patterns of detrusor overactivity (DO) with the severity of the symptoms related to overactive bladder (OAB) in men with benign prostatic enlargement (BPE) associated with DO.MethodsA total of 777 men with symptomatic BPE who had undergone transurethral resection of the ...
Nouval, Shahab, Narihito, Seki, Ryosuke, Takahashi, Shunichi, Kajioka, Mineo, Takei, Akito, Yamaguchi, Seiji, Naito   +6 more
openaire   +2 more sources

OnabotulinumtoxinA in Refractory Neurogenic Detrusor Overactivity

European Urology, 2011
OnabotulinumtoxinA (Botox; Allergan, Inc., Irvine, CA, USA) is expected to be licensed for treatment of neurogenic detrusor overactivity (NDO) soon. This is the culmination of a long journey that has taken >10 yr. Researchers worldwide, both basic science and clinical, and many thousands who have received the treatment on a ‘‘named patient basis’’ are ...
openaire   +3 more sources

Detrusor overactivity—an update

BJOG: An International Journal of Obstetrics & Gynaecology, 2004
P, Toozs-Hobson, A, Elnaqa
openaire   +2 more sources

Detrusor overactivity

Obstetrics, Gynaecology & Reproductive Medicine, 2007
Richard Foon, P. Toozs-Hobson
openaire   +1 more source

Detrusor Overactivity

Current Obstetrics & Gynaecology, 2004
Amitabha Majumdar, Philip Toozs-Hobson
openaire   +1 more source

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder

Neurourology and Urodynamics, 2014
Overactive bladder (OAB) is a symptom syndrome consisting of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence (UUI), in the absence of a causative infection or pathological conditions. The prevalence of OAB is approximately 11–19% in both men and women, and leads to a significant negative ...
openaire   +2 more sources

[NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].

Urologiia (Moscow, Russia : 1999), 2015
The purpose was to determine the concentration of the neurotrophin nerve growth factor in urine to assess its possible role as a marker in the diagnosis of various forms of overactive bladder. The study included patients with urinary frequency and urgency: 21 patients with idiopathic detrusor overactivity, 18--with overactive bladder without detrusor ...
G G, Krivoborodov, E F, Kolesanova, E I, Tur, N S, Efremov   +3 more
openaire   +1 more source

Drug treatment of the overactive detrusor

Acta Pharmacologica et Toxicologica, 1980
K E, Andersson, U, Ulmsten
openaire   +2 more sources